Aim: Antimicrobial resistance poses a major global health crisis, with some bacterial strains now resistant to nearly all available antibiotics. Carbon quantum dots (CQDs) have emerged as promising nanomaterials for broad-spectrum infection prevention owing to their multiple antibacterial mechanisms, biocompatibility, and cost-effectiveness. Many reported CQD fabrication methods rely on synthetic chemicals, which increase production costs and potentially compromise the biocompatibility of the resulting CQDs. Although green-synthesized CQDs have attracted considerable attention for antibacterial applications, limited studies have investigated the use of natural, food-derived components to tune CQD surface charge and its influence on antibacterial activity and mammalian cell compatibility. This study aims to develop CQDs with tunable surface charges from natural food-derived carbon sources for broad-spectrum antibacterial applications. Methods: Whole-meal bread and soybean flour were used as biogenic precursors to synthesize negatively charged CQDs via a simple hydrothermal method. Surface charge was adjusted to neutral and positive by incorporating lemon juice and chitosan during synthesis. Antibacterial activity and mammalian cell viability were evaluated. Results: Bread- and soybean-derived CQDs exhibited negative surface charges (–15 mV) due to abundant carboxyl and hydroxyl groups formed during precursor decomposition. Addition of lemon juice altered the surface chemistry by introducing balanced protonated and deprotonated species, producing zwitterionic CQDs with near-neutral charge (–0.1 mV). Further incorporation of chitosan introduced protonated amine groups (–NH3+), yielding positively charged CQDs (+10 mV). At an optimal concentration of 10 µg/mL, both neutral and positively charged CQDs demonstrated moderate broad-spectrum antibacterial activity (30–40% inhibition) against Gram-negative and Gram-positive bacteria. Their antibacterial effect was attributed to favorable electrostatic interactions with negatively charged bacterial cell envelopes, causing membrane disruption, reactive oxygen species (ROS)-induced damage, and intracellular interference. In contrast, mammalian cells maintained 100% viability, likely due to their flexible cholesterol-rich membranes, stronger antioxidant defense systems, and intracellular compartmentalization. Conclusions: This study demonstrates a reagent-free and sustainable approach for producing CQDs with controlled surface charges from natural precursors. The resulting CQDs show strong potential as safe and effective antibacterial nanomaterials for biomedical applications.
Lignin-based hydrogels are gaining recognition as promising biomaterials for medical applications, especially in drug delivery. This is due to their biocompatibility, biodegradability, and tunable properties. This review presents an analysis of the mechanisms and kinetics of drug release from lignin-based hydrogels, focusing on their synthesis, functional properties, and applications. It begins by detailing the composition and synthesis methods of lignin-based hydrogels, emphasizing their unique structural features that facilitate controlled drug release. The review also discusses the mechanisms of drug release, including diffusion, swelling, and degradation-controlled processes, and how these mechanisms impact release kinetics. Key factors influencing drug release, such as hydrogel composition, crosslinking density, and environmental conditions (e.g., pH, temperature, and bio-factors), are critically examined. Additionally, the review explores the use of mathematical models, such as the zero-order, first-order, Higuchi, and Korsmeyer-Peppas models, in predicting and optimizing drug release profiles. Summaries of experimental studies, both in vitro and in vivo, demonstrate the potential of lignin-based hydrogels in targeted and controlled drug delivery systems. Despite their potential, challenges such as limited clinical translation and scalability persist. The review concludes by identifying future research directions to address these challenges and further advance the application of lignin-based hydrogels in drug delivery. By integrating insights from recent studies, this review highlights the transformative potential of lignin-based hydrogels in enhancing therapeutic outcomes and advancing biomedical technologies.
Biodegradable hydrogels are injected in situ to create scaffolds in complex tissue defects with a minimally invasive approach. The current narrative review critically discusses their design principles such as polymer type (natural, synthetic and hybrid systems), crosslinking processes (physical, chemical, and self-crosslinking strategies), and optimization of their rheological properties for clinical injectability. Various advanced biofunctionalization strategies such as cell encapsulation, spatiotemporal delivery of growth factors, extracellular matrix mimicry via fiber-reinforced composites, and active immunomodulation are assessed for their application in tissue-specific regeneration in cartilage, bone, cardiac, neural, skin, and dental applications. While there has been significant progress in preclinical work, there are significant translational challenges that remain: mechanical mismatch with load-bearing native tissues, natural polymer batch-to-batch variability, unpredictable degradation rates, and a complex regulatory pathway for combination products. We explore under-explored areas such as 4D bioprinting for dynamic shape morphing, the design of materials through artificial intelligence, and closed-loop theranostic platforms that combine real-time biosensing with on-demand therapeutic release. This review suggests that the interdisciplinary convergence of materials science, bioengineering, and regulatory science is necessary to tackle these challenges and make injectable hydrogels a standard-of-care regenerative therapeutic.
This study explores bioinspired anesthetic delivery systems as an emerging approach to integrate pain management with tissue regeneration. It highlights limitations of conventional anesthetics by short half-lives, narrow therapeutic windows, and the risk of systemic toxicity, highlighting the need for safer and longer-acting alternatives. Drawing inspiration from natural biological systems, including cell membrane-derived nanocarriers and self-assembling peptides, bioinspired platforms offer innovative approaches for controlled and targeted drug delivery. Significantly, growing evidence demonstrates that the nervous system actively participates in tissue repair processes, necessitating anesthetic strategies that alleviate pain without impairing regeneration. In this context, the development of dual-functional delivery systems, particularly hydrogel nanoparticle composites, represents a promising solution, enabling sustained analgesia while concurrently promoting tissue healing. The review further addresses key translational barriers, including manufacturing scalability, regulatory complexities associated with combination products, and technical challenges such as burst release. By outlining strategic pathways for clinical translation, this work underscores the transformative potential of multifunctional, bioinspired delivery platforms in advancing chronic pain therapy and regenerative medicine.
Lignin, the second most abundant natural polymer after cellulose, has emerged as a promising renewable resource for developing functional biomaterials. Due to its aromatic structure and abundance of phenolic, hydroxyl, and methoxy groups, lignin exhibits intrinsic antioxidant, UV-blocking, antimicrobial, and biocompatible properties, making it an attractive candidate for hydrogel fabrication. This review provides a comprehensive overview of lignin-based hydrogel, focusing on their structural characteristics, extraction methods, and strategies used for hydrogel preparation, including crosslinking copolymerization, graft polymerization, interpenetrating polymer networks, and controlled polymerization techniques such as ATRP and RAFT. Particular emphasis is placed on recent advances in the application of lignin-based hydrogels in biosensing and biomedical fields, including wearable strain and pressure sensors, drug delivery systems, wound healing, and tissue engineering. The multifunctional properties of lignin contribute to enhanced mechanical strength, electrical conductivity, UV protection, and controlled drug release, enabling the design of smart and sustainable hydrogel systems. Despite these advantages, several challenges remain that limit large-scale translation, including lignin heterogeneity, limited solubility, variability in hydrogel performance, and potential impurities from industrial extraction processes. Addressing this limitation through improved lignin purification, chemical modification, and standardized synthesis approaches will be essential for advancing lignin-based hydrogels towards practical biomedical and sensing applications.
The development of biomaterials capable of supporting complex tissue growth remains a central challenge in regenerative medicine and tissue engineering, particularly in replicating the structural, mechanical, and transport functions of native extracellular matrices. While decellularized animal tissues have demonstrated significant success as scaffolds for tissue engineering, they are still constrained by cost, immunogenicity, and ethical concerns. In recent years, decellularized plant tissues have emerged as a compelling alternative scaffold platform due to their inherent vascular architectures, ethical sourcing, tunable mechanical properties, cytocompatibility, and sustainability. This review summarizes current strategies for the decellularization of plant tissues, including chemical, enzymatic, and physical approaches, and discusses how these methods preserve plant cell wall structure while removing immunogenic components. Advances in surface loading and functionalization, including protein coatings, oxidation, nanoparticle incorporation, peptide conjugation, and bioactive molecule loading, have further enhanced cell adhesion, differentiation, biodegradability, and immunomodulation. Recent applications of decellularized plant scaffolds in cardiac, skeletal muscle, bone, nerve, and wound healing contexts are reviewed, highlighting proof-of-concept successes and remaining challenges. Beyond therapeutic applications, plant-derived scaffolds have also enabled physiologically relevant in vitro models for vascular biology, mechanotransduction, cancer, metabolic tissues, and drug response studies. Collectively, these advances position decellularized plant tissues as versatile, low-cost, and ethically favorable biomaterials with growing relevance for both regenerative medicine and tissue modeling.
Hydrogels are increasingly explored as functional wound-dressing materials because they combine high water content, biocompatibility, structural tunability, and the ability to localize therapeutic delivery at injured tissue. As biomaterial platforms, hydrogel dressings can maintain a moist microenvironment, absorb exudate, protect the wound bed, and carry bioactive agents that modulate infection, inflammation, oxidative stress, and tissue regeneration. This review examines hydrogel wound dressings from a materials centered perspective. First, skin structure, wound-healing physiology, and major barriers to repair are outlined to define the biological requirements for effective dressings. Next, the chemical composition of natural, synthetic, and composite hydrogels, their crosslinking strategies, swelling behavior, and drug-loading and release mechanisms are discussed in relation to wound healing performance. Recent progress in infection responsive, stimuli responsive, growth factor delivering, antimicrobial peptide loaded, and self-healing hydrogel systems is then summarized. The present review highlights how composition, network architecture, and responsiveness govern biomedical function and localized drug delivery in wound care. These insights provide a materials centered framework that connects hydrogel composition, network architecture, responsiveness, and localized delivery behavior with wound healing performance, thereby supporting the rational design of next generation hydrogel biomaterials for difficult to heal wounds.
Aim: In biosensor technology, reliable attachment of protein-based probes requires careful control of the orientation of the probe molecule on the biosensor surface. In this regard, polyhistidine peptide became an attractive target for on surface immobilization. The present contribution details the total synthesis and the surface chemistry of a new antifouling organotrichlorosilane linker bearing a head function designed to immobilize the imidazole side chain of histidine for future immobilizations with polyhistidine peptide onto biosensor surface. Methods: A novel organotrichlorosilane linker bearing the ethylene glycol backbone and a 2-chloroethyl sulfone head function (which can be converted to the vinyl sulfone group for subsequent attachment with imidazole) were synthesized via a multiple-step synthesis and carefully characterized. Surface modifications using the synthesized novel organotrichlorosilane linker, subsequent conversion to vinyl sulfone head function, and treatment with N-protected histidine were demonstrated on black lithium niobate substrate. Results: Novel organotrichlorosilane linker was successfully synthesized, though it was also observed that organotrichlorosilane linker was quite moisture reactive. Surface characterizations also indicated successful modification of lithium niobate with the novel organotrichlorosilane linker as well as presence of N-protected histidine on the lithium niobate surface post-immobilization. Conclusions: A novel organotrichlorosilane linker bearing the 2-chloroethylsulfone group was successfully synthesized and successful immobilization with N-protected histidine was demonstrated. The surface chemistry demonstrated onto lithium niobate herein is immediately applicable for future on-surface immobilization of protein-based probe molecules bearing polyhistidine moieties.
Ultra-high molecular weight polyethylene (UHMWPE) is widely used as a key material in biomedical implants such as artificial joints due to its exceptional wear resistance, high impact strength, and good biocompatibility. However, its inherent bio-inertness, hydrophobicity, risk of osteolysis induced by wear debris, and insufficient mechanical and processing properties severely limit its long-term clinical performance. This review systematically summarizes recent advances in the functional enhancement of UHMWPE via hybrid strategies, including surface modifications (e.g., coatings, chemical grafting, laser processing, plasma treatment) and bulk blending modifications (involving both organic and inorganic composites). These approaches have been shown to significantly improve wear resistance, bioactivity, hydrophilicity, and mechanical properties, while effectively suppressing oxidative degradation and inflammatory responses. The current challenges in modification technologies, such as balancing multiple properties, ensuring long-term biosafety, and achieving clinical translation, are also discussed. Finally, future directions toward multifunctional integration, intelligent responsiveness, and personalized customization of implants are outlined, providing critical insights for the development of next-generation high-performance and long-lasting biomedical materials.
The emergence of stem-cell-derived enamel organoids and dentin-producing dental pulp stem cell constructs presents new possibilities for restoring carious lesions using autologous enamel–dentin inlays. This overview outlines the biological and technological advances supporting this approach and proposes a workflow oriented toward clinical application. The benefits of tissue-based inlays, including inherent biomechanical compatibility, aesthetic accuracy, and potential for biological integration, are contrasted with those of purely artificial materials. Significant regenerative developments include the formation of human enamel organoids and odontoblast-lineage cells in vitro, 3D bioprinting of tooth-shaped constructs with demineralised dentin matrix and poly(ε‑caprolactone) scaffolds, and fibre-guiding periodontal ligament scaffolds that restore Sharpey’s fibres in vivo. The mechanical performance of adhesive resin cements, with bond strengths of approximately 4–7 MPa to enamel and dentin, and their durability in reattaching natural tooth fragments, supports the feasibility of bonding biological inlays. Practical considerations include controlling the slow degradation and hydrophobicity of poly(ε-caprolactone) through the use of ceramic or natural polymer additives, employing multi-material 3D printing to co-print mineralized enamel and cell-laden dentin layers, and achieving the desired shade, microstructure, and mechanical properties, exemplified by a compressive strength of approximately 677 MPa for 3D-printed zirconia crowns. Despite regulatory and translational challenges, the integration of digital dentistry, bioprinting, and stem cell science points toward future “grow and glue” restorations that may replace traditional drill-and-fill methods.
Aim: Although polytetrafluoroethylene (PTFE) is more hydrophobic than polyvinylidene fluoride (PVDF) in fluorocarbon polymer (FCP) membrane filters, it has been reported that the rate of amyloid fibril formation is faster on PVDF than on PTFE. To clarify whether the effect is due to the membrane’s chemical structure or its hydrophobicity at the membrane interface, studies on amyloid fibril formation were conducted using both hydrophobic and hydrophilic PVDF and PTFE membranes. Methods: Heat-treated insulin (INS) was adsorbed onto the FCP membrane filters. Gaussian integrals were employed to determine the amounts of β-sheet and their abundance ratios by curve fitting of attenuated total reflection Fourier transform infrared spectra. Results: Adsorbed heat-treated INS onto the FCP membrane filters showed a β-sheet form, with a similar or higher affinity in comparison with that of the β-rich concanavalin A. The adsorption followed a sigmoidal curve with a 2-hour lag time, reaching a plateau after 4–5 hours. The spectral patterns of the adsorbed INS indicated the β-sheet form, demonstrating that INS transformed into β-sheet and then, or simultaneously, adsorbed onto the FCP membrane filters. Conclusions: The results regarding the rate and strength of amyloid fibril formation for each FCP membrane filter suggest that, beyond the membrane’s surface hydrophobicity or hydrophilicity, other factors, such as the electron affinity of hydrogen in the PVDF membrane, also influence nucleation. This study provides insight into the role of INS in amyloid fibril formation within FCP membrane filters.
Hydrogels are among the most intensively studied biomaterials for controlled drug delivery, yet translation to routine clinical practice has been limited by rapid diffusion of small molecules and instability of biologics. In their recent report in Nature Nanotechnology (Pogostin et al., 2025, DOI: 10.1038/s41565-025-01981-6), a team from Rice University and collaborators present a nanofibrous supramolecular peptide hydrogel system that addresses these challenges through the incorporation of dynamic covalent chemistry. The SABER (Self-Assembling Boronate Ester Release) platform introduces reversible boronate ester bonds between engineered peptide fibers and boronic acid modified therapeutics, creating a tunable and long-acting drug release system. Proof-of-concept applications included tuberculosis therapy, diabetes management, and prolonged antibody delivery, demonstrating both versatility and clinical relevance. In this Commentary, I situate this advance within the broader trajectory of hydrogel research, highlight the conceptual novelty of dynamic supramolecular interactions, and discuss the opportunities and challenges for clinical translation. I argue that this platform signals a paradigm shift in drug delivery, moving hydrogels from passive depots to dynamic partners in medicine.
Luminescent markers have been widely used in medicine, biology, agrotechnology, and for marking nuclear wastes and consumer goods. The high sensitivity and selectivity of the markers/labels allow the detection of various substances and the obtaining of valuable information about the distribution of constituents in specific media. This review describes the state of the art in luminescent marking/labeling of various cellulose forms, including nanosized ones, cellulose derivatives, and cellulose-containing materials. The importance of this consideration is explained by the role of cellulose and its derivatives in human life and their overall impact on mankind’s development. The structure and luminescence properties of cellulose and other related materials and cellulose derivatives are discussed from the viewpoint of cellulose luminescent “self-labeling”. It is shown that dyes, organic molecules, and organic-inorganic complexes, as well as inorganic dielectric and semiconductor micro/nanoparticles, can be effectively applied for the purposes of cellulose luminescent marking/labeling. This review discusses various application examples and explains the performance and mechanisms of various systems labeling (e.g., dye-cellulose, quantum dot-cellulose complex) in these applications. The review not only comprehensively summarizes existing approaches to luminescent labeling of cellulose-containing materials. It also highlights problematic issues that arise for developers of new luminescent markers (quenching of luminescence in an aqueous environment, the need to functionalize the luminescent marker material, etc.). At the same time, this work demonstrates the prospects for luminescent labeling data in modern digital technologies, particularly in the Internet of Things (IoT).
Aim: Osimertinib’s clinical application is limited by poor aqueous solubility and systemic toxicity. Nano-niosomal formulations can address these challenges by providing controlled release and enhancing delivery. To develop and systematically evaluate nano-niosomal formulations of osimertinib using different surfactants, focusing on physicochemical characteristics, release kinetics, and cytotoxic activity. Methods: Four niosomal formulations were prepared using Span 60, Tween 60, Pluronic F-127, and Brij 52 (each at a 1:1 cholesterol-to-surfactant ratio). Particle size, zeta potential, and entrapment efficiency were measured. In vitro drug release was analyzed using Franz diffusion cells and fitted to standard kinetic models. Cytotoxicity was assessed by MTT assay in KAIMRC-2, MDA-MB231, and HCT-116 cell lines. Vesicle morphology was visualized by transmission electron microscopy. Results: All nano-niosomal formulations showed nanoscale particle sizes (47–292 nm), negative zeta potentials (−18.7 to −26.5 mV), and high entrapment efficiencies (69.8%–76.2%). Release studies indicated Span 60, Tween 60, and Pluronic F-127 followed diffusion-controlled kinetics (Higuchi/Korsmeyer–Peppas model, R2 up to 0.97), while Brij 52 provided a sustained zero-order release (R2 = 0.98). Compared to free osimertinib, all niosomal systems significantly prolonged release. Cytotoxicity studies demonstrated that all formulations enhanced anti-cancer effects, with Span 60-based niosomes exhibiting the greatest potency across cell lines. Conclusions: Optimized nano-niosomal encapsulation of osimertinib enables sustained and controlled drug release, improved cellular uptake, and enhanced cytotoxicity in vitro. Differences in surfactant composition critically influence formulation performance, supporting the further development of niosomal osimertinib as a promising strategy for oncological drug delivery applications.
Aim: Peripheral nerve injuries (PNIs) often result in a diminished quality of life for those affected and are the most common nervous system injury, with limited treatment options. Regenerative medicine presents novel biomaterial and cell-based therapies to repair the damaged tissue. Graphene oxide (GO), and mesenchymal stem cells (MSCs) have the potential to serve as components to treat PNI. This study evaluates the systemic toxicity of GO and xenogenic human MSCs by analyzing the peripheral blood immune phenotype when a novel nerve guidance conduit (NGC) is implanted in a rat model for six months. Methods: A 10-mm long sciatic nerve defect model was created in 8–10-week-old Lewis rats. Four treatment groups were generated: autograft (positive control), poly (lactic-co-glycolic acid) (PLGA) NGC, PLGA NGC with 0.25% GO, and PLGA/GO NGC seeded with 1 × 106 human adipose-derived MSCs. Tail blood was collected before surgery, and at 24 hours, 2 weeks, 2, 3, 5, and 6 months after surgery. Hematological analyses were carried out to evaluate systemic changes, if any, in peripheral immune cell types, namely, T lymphocytes, B lymphocytes, natural killer cells, and macrophages. The treated and contralateral sciatic nerves were excised, paraffin embedded, sectioned, and H&E stained, to identify any local foreign body rejection. Results: Treatment groups with GO and MSCs displayed percent total values of peripheral immune cells equivalent to the autograft at each time point. There was no evidence of an inflammatory response in the histological samples. Conclusions: The lack of changes in immune phenotype demonstrates a lack of nanotoxicity of the graphene nanoparticles and no evidence of adverse effects due to the MSCs. This was further supported by a lack of local foreign body response at the site of implantation. Overall, the PLGA/GO NGC + MSCs construct is biocompatible for six months in a rat PNI model, exhibiting a potential for clinical translation.
The challenges of conventional animal models and two-dimensional (2D) in vitro cell cultures in effectively forecasting human toxicity have prompted a significant shift towards New Approach Methodologies (NAMs). This development centers on advanced humanized in vitro co-culture models that offer improved physiological relevance for toxicological assessment. This perspective highlights the critical role of biomaterials in the creation of complex microenvironments. This study demonstrates how biomaterials effectively mimic the original extracellular matrix (ECM) through controlled compositional, structural, mechanical, and biochemical signals, thereby enabling the development of sophisticated 3D spheroids, organoids, and Organ-on-Chip systems. These biomaterial-enhanced platforms are essential for precise evaluation of immunotoxicity, as they promote human-specific immune responses and targeted immunomodulation, and for carcinogenicity, as they accurately replicate the tumor microenvironment, affect cancer cell behavior, and enable patient-derived models. Moreover, we underscore the synergistic amalgamation of these biomaterial-based models with omics technologies and computational methodologies (QSAR, AI/ML) for thorough molecular insights and rational design. Despite ongoing challenges in standardization and high-throughput compatibility, the strategic utilization of biomaterials is set to transform predictive toxicology, expedite drug discovery, and promote personalized medicine, thereby diminishing dependence on animal testing and improving human safety.
Aim: To evaluate the precision of computer-assisted surgery simulation in mandibular condyle reconstruction using a costochondral graft. Methods: Ten patients (mean age: 14.5 years) with temporomandibular joint (TMJ) pathology and associated pain were included in the study. All patients underwent TMJ reconstruction using costochondral grafts planned through computer-assisted surgical simulation. Preoperative assessment included mouth opening, facial asymmetry, and the differences between planned and actual mandibular positioning. Results: Postoperative mouth opening was significantly improved in all patients, and facial profile modifications were enhanced. The site of the costochondral graft relative to the glenoid fossa was found to be satisfactory in postoperative radiographs, computed tomography images, and quantitative analysis. Conclusions: The results of this study demonstrate that virtual surgical planning combined with 3D-printed guiding templates enhanced treatment planning, provided precise osteotomy guidance, facilitated accurate repositioning of bony segments, and improved the contouring of mandibular anatomy in the management of TMJ deformities (ClinicalTrials.gov identifier: NCT06811415).
Graphene-based nanomaterials are promising candidates for neuromuscular regeneration due to their electrical conductivity, mechanical strength, and functionalizability. In this perspective, reduced graphene oxide (rGO) nanocomposites decorated with gold nanoparticles (AuNPs) or silver nanoparticles (AgNPs) were synthesized via a one-step green process using Camellia sinensis (tea) extracts. The extracts acted as reducing and stabilizing agents and left bioactive catechins and polyphenols adsorbed on the graphene surface. The resulting nanocomposites combined structural support, electrical conductivity, and bioactive molecular modulation. rGO can provide scaffolding for cell growth, while the retained plant metabolites contributed antioxidant and anti-inflammatory effects. Incorporation of metallic nanoparticles enhanced mechanical strength, surface reactivity, and antimicrobial properties. These multifunctional graphene-metal nanocomposites offer a sustainable and biocompatible platform for guiding neuromuscular regeneration and represent a promising basis for future clinical translation.
Indications for resection of maxillofacial and mandibular skeletal structures include extirpation of benign and malignant tumors, trauma, and congenital defects. Reconstruction of these structures often demands free tissue transfer incorporating bone and/or soft tissue with placement of rigid titanium implants to span the bony defect and anchor the autologous bone. Historically, such implants were mass-produced in standard formats, requiring manual bending during surgery to the patient’s specific bony anatomy. Recent technological and manufacturing advancements have permitted the use of three-dimensional (3D) printed, patient-specific maxillofacial and mandibular reconstructive prosthetics and implants. Preoperative 3D printing of patient-specific prosthetics and implants composed of titanium has revolutionized maxillofacial and mandibular reconstructive surgery and has been associated with improvements in operative efficiency, enhanced functional outcomes, and reduced complication rates in early studies. Herein, we review the history and current state of metal 3D printing of prosthetics and implants for head and neck oncologic reconstruction and posit future directions for innovation and surgical refinement in this area.
